ProCE Banner Activity

Luspatercept: Practical Insights on a New Therapy for Adults With Transfusion-Dependent β-Thalassemia

Clinical Thought
Are you prepared to use the newly approved erythroid maturation agent luspatercept in the care of your adult patients with transfusion-dependent β-thalassemia?

Released: January 13, 2020

Expiration: January 11, 2021

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Celgene